Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205439 · ClinicalTrials.gov registry record
Surveillance For New Lung Primaries
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 200
- Enrollment target
NCT00205439: Clinical Trial study, sponsored by University of Wisconsin, Madison.
NCT00205439 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00205439 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The primary goal of this study is to determine the prevalence of tracheobronchial carcinomas in patients with a history of squamous cell cancer of the aerodigestive tract who have been treated with a curative intent and remain disease free. Detection of pre-invasive and invasive lesions (moderate to severe dysplasia, CIS) with fluorescence bronchoscopic surveillance may help to define the natural history of these lesions and allow earlier intervention should they progress to invasive lesions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2001-12 |
| Est. Completion | 2005-12 |
Why NCT00205439 stopped before completion
NCT00205439 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00205439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00205439 about?
NCT00205439 is a clinical study titled "Surveillance For New Lung Primaries". The primary goal of this study is to determine the prevalence of tracheobronchial carcinomas in patients with a history of squamous cell cancer of the aerodigestive tract who have been treated with a curative intent and remain disease free. Detection of pre-invasive and invasive lesions (moderate to...
What is the current status of trial NCT00205439?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2001-12. Estimated completion is 2005-12.
Who is sponsoring clinical trial NCT00205439?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia